Apollo Commercial Real Estate Finance Inc (ARI) Stock News

Roivant and Priovant announced positive Phase 3 results for brepocitinib in treating non-infectious uveitis. The drug met primary and secondary endpoints in both CLARITY-1 and CLARITY-2 trials, with 62% of patients achieving steroid-free quiescence at Week 48 compared to 20% on placebo. The companies plan to file a supplemental New Drug Application in the first half of 2027.

Ferrari N.V. announced the purchase of 43,000 common shares between October 5-9, 2026, as part of its €250 million third tranche share buyback program. The company invested €114.8 million at an average price of €344.08 per share on Euronext Milan. Since January 2026, Ferrari has purchased 2,032,307 shares for a total consideration of €627.7 million under its multi-year €3.5 billion buyback initiative expected to conclude by 2030.

Aclarion announced revised inclusion/exclusion criteria for its CLARITY clinical trial to accelerate patient enrollment. The new criteria, approved at 9 of 11 active sites, better reflect real-world chronic low back pain patients while maintaining scientific rigor. The company expects meaningful enrollment acceleration and will provide an updated timeline for initial readout by year-end, though the overall trial duration remains on track.

Ferrari S.p.A. has signed a partnership agreement with Rakuten Group, Inc., a global technology company, effective from January 1, 2027. The partnership aims to leverage Rakuten's technology capabilities with Ferrari's luxury automotive brand.

Oliveda International, Inc. (OLVI) announced the launch of ARISTAEOS by its Olive Tree People subsidiary, combining grass-fed bovine colostrum with hydroxytyrosol derived from the company's eco-certified Andalusian olive trees. The product represents a new category combining colostrum with olive tree-derived ingredients, marking the company's expansion into nutritional supplements alongside its existing waterless beauty product line.

Ferrari N.V. has purchased 35,641 common shares across Euronext Milan and NYSE as part of its third tranche of a multi-year €3.5 billion share buyback program announced during the 2025 Capital Markets Day. As of September 4, 2026, the company has invested €523.4 million to repurchase 1,736,825 shares since January 5, 2026, representing 0.92% of total issued common shares.

Ferrari N.V. has completed its €250 million second tranche of share buybacks, purchasing 815,739 common shares across Euronext Milan and NYSE for €249.999 million. The company announced a third tranche of up to €250 million starting September 2, 2026, to be executed through non-discretionary agreements with primary financial institutions. Since January 2026, Ferrari has repurchased 1,701,184 shares totaling €510.76 million as part of its €3.5 billion multi-year buyback program expected to conclude by 2030.

BNP Paribas has issued a statement regarding ongoing Sudan litigation, asserting that the trial court misinterpreted Swiss law and committed legal errors. The bank claims its financial transactions were authorized under Swiss and European law, and states it has support from the Swiss and US governments, academics, and professional organizations. BNP Paribas expressed confidence in presenting its case before the appellate court.

BNP Paribas has filed an appeal in Sudan litigation, asserting that the trial court misinterpreted Swiss law and committed legal errors. The bank claims its financial transactions were authorized under Swiss and European law, and states it has support from the Swiss government, US government, academics, and industry organizations in its position.

Arval, a BNP Paribas subsidiary, has completed its acquisition of Athlon (formerly a Mercedes-Benz Group subsidiary), creating a European co-leader in long-term vehicle leasing with a combined fleet of 2.3 million vehicles. The transaction is expected to deliver an 18% ROIC and contribute approximately €200 million to net income by year 3, with a modest -13 bps CET1 impact.

Arval, a BNP Paribas subsidiary, has completed its acquisition of Athlon (formerly Mercedes-Benz Group's subsidiary) on July 31, 2026. The combined entity now manages 2.3 million vehicles, establishing itself as a co-leader in European long-term vehicle leasing. The acquisition is expected to deliver an 18% return on invested capital and contribute approximately €200 million to net income by year three, with a -13 basis point impact on the CET1 ratio.

The CLARITY Act, which aims to establish a clear federal framework for regulating digital assets, is being revised in the Senate with a potential vote after mid-September. Passage could benefit Coinbase and Robinhood by allowing stablecoin yields and shifting crypto oversight to the CFTC, though the author favors Robinhood as a safer long-term investment due to its diversification and steadier growth compared to Coinbase's tight dependence on the crypto market.

Ferrari N.V. announced the completion of its second tranche of a €250 million share buyback program on the Euronext Milan and NYSE exchanges. Between July 20-24, 2026, the company purchased 57,800 common shares at an average price of €321.35. Since the program's inception in January 2026, Ferrari has repurchased 1,612,475 shares for a total consideration of €479.4 million as part of its multi-year €3.5 billion buyback initiative through 2030.

BNP Paribas announces a pre-stabilisation period for CLARIANE SE's EUR 333 million perpetual undated subordinated fixed rate resettable notes offering. The stabilisation period is expected to run from June 23, 2026 to July 29, 2026, with multiple stabilisation managers appointed to support the market price of the securities during this period.

Law firm Bragar Eagel & Squire is investigating Claritev Corporation following a DOJ criminal price-fixing investigation into the company's Data iSight pricing tool, reported by The Capitol Forum on May 14, 2026. The announcement triggered a sharp 41% stock price decline, dropping from $23.47 to $13.87 per share. The firm is seeking stockholders who suffered losses to discuss potential legal claims.